 comparison efficaci safeti pergolid bromocriptin treatment hyperprolactinemia pergolid synthet ergolin deriv potent long-act prl-lower activ therapi hyperprolactinemia daili administr drug result open-label clinic trial pergolid day bromocriptin time efficaci safeti reduct prl level cessat galactorrhea amenorrhea improv sexual function tumor shrinkag hyperprolactinemia trial patient evid pituitari tumor trial II patient drug effect prl level trial median optim dose microgram mg bromocriptine/day prl level patient trial investig period galactorrhea patient wherea menstruat patient high efficaci optim median dose microgram mg bromocriptin trial II resumpt mens frequent patient trial patient sexual dysfunct drug patient addit tumor shrinkag similar extent drug high incid advers event initi therapi compound nausea dizzi asthenia headach decreas blood pressur similar incid extent use pergolid bromocriptin patient trial pergolid incid fever vasodilat flu syndrom conclus studi total hyperprolactinem patient daili administr pergolid safe effect time daili ingest bromocriptin longer-act dopamin agonist daili like eas therapeut regimen complianc medic treatment hyperprolactinemia